With the presentation of the book My Life in Cuba, an autobiography in vignettes by Juan Padrón, the 14th edition of the Comic Art Conference began at the Nuevo Mundo Room in this city.

Read more ...

The production of food for the population remains one of the primary objectives for the entities in charge of these matters in Guáimaro, a municipality of Camagüey.

Read more ...

The Arte Plaza circuit as a creative industries project in the historic center of this city culminates its promotion stage with international financing and must grow from the self-management of entrepreneurs and local actors.

Read more ...

The 16th International Symposium on Challenges in the Administration and Management of Cities left firsts in its farewell, gratitude to the participants and the invitation to return in 2026 to focus on challenges and opportunities of the historic urban landscape.

Read more ...

The University of Camagüey Ignacio Agramonte Loynaz, the first created by the Revolution, made progress during 2023 in the development of projects for the application of artificial intelligence techniques.


City postcard

We had not been able to see the city for days. A cloud of dust everywhere. Scaffolding and house painters. The noisy and hurried work of builders to finish the work, because even at home when we don't set a date for our goals, we leave things for later... and then we don't do anything.


Although they are mentioned more at the beginning of December, when World HIV Response Day is celebrated, in Cuba there is a Care Program for patients living with HIV-AIDS that has been working continuously and has been operating since 1986. Dr. Yadira Betancourt Camargo, specialist in Internal Medicine, and Dr. Miguel Obediente Tan, Comprehensive General Physician, assume responsibility for said program in the province. Adelante spoke with her.


The first newspaper founded by the Cuban Revolution, Adelante, celebrated a new birthday with the mission of being the voice of the people of the largest region of the largest of the Antilles.


A total of 28 people, of 94 evaluated in Camagüey, have been included to be favored with the clinical trial of NeuralCIM (nasal drops) in patients with the phenotype of suffering from Alzheimer's, with the purpose of stopping the disease.